Alvotech moves to bring its Humira biosimilar to US market
Hot on the heels of a US Food and Drug Administration (FDA) approval for Alvotech and Teva Pharmaceuticals’ Simlandi (adalimumab-ryvk), Alvotech has announced a long-term agreement with a strategic partner to increase US market access to the Humira ( …